Growth equity

Oceanpine targets growth equity investments in green tech, advanced tech, and healthcare assets in China and overseas.

After a blurring of the lines with venture and buyout strategies, market conditions are bringing greater clarity to growth capital.

Macro challenges are prompting different value-creation priorities to come to the fore, but the underlying fundamentals of the asset class remain intact.

The days of a near exclusive focus on revenue expansion are over as the emphasis shifts to profitable growth, say Matthew Hobart and David Trujillo, co-managing partners at TPG Growth.

The Maryland-headquartered multifamily office has its eye on small growth and buyout managers with specialist strategies across North America and Western Europe.

Speaking at the HKVCA’s China Private Equity Summit on Tuesday, the firm’s head of private and growth equity in APAC said she spends more time in the Middle East and Southeast Asia when fundraising.

The pair are taking equal stakes in the mid-market-focused investment firm in a Houlihan Lokey-advised transaction.

The number of vehicles to wrap up fundraising during the first quarter suggests total funds to close this year could fall by half, according to PEI data.

Falling valuations and increasing emphasis on efficient and sustainable growth by private companies are likely to make conditions ripe for growth capital investing, say Adams Street Partners’ Robin Murray, Tom Bremner and Fred Wang.